Welcome to SynThink Blog
Here, we keep you posted about the latest updates and insights into pharmaceutical impurities. We understand that impurities in pharmaceuticals can significantly impact their safety and efficacy, and it is crucial to maintain stringent standards to ensure quality of the products. Our blog site provides the most accurate and up-to-date information on impurity standards, regulations, and guidelines in the pharmaceutical industry. We hope you find our blogs informative and valuable.
Impurity Isolation vs Chemical Synthesis: Which Strategy Truly Wins?
Pharmaceutical impurities are unavoidable in the drug manufacturing process. They are also known as API impurities.
Regulatory Requirements for Impurity Reference Standards
API impurity reference standards are essential tools in pharmaceutical analysis. They ensure accurate identification, quantification, and control of impurities in drug substances and products.
Mutagenic Impurities Risk Assessment Under ICH M7
In pharmaceutical manufacturing the mutagenic impurities are among the most critical safety concerns. These impurities are responsible for the damage of DNAs, even at trace levels.
Understanding ICH Q3C: Residual Solvents in APIs Explained
The International Council for Harmonisation (ICH) provides clear guidelines for the solvents’ impurities in Active Pharmaceutical Ingredients (APIs).
2026 Update on Pharmaceutical Standards
For multinational pharmaceutical companies, CDMOs, biotech innovators, and API manufacturers operating across multiple jurisdictions, regulatory alignment is now a strategic priority
ICH Q3A vs Q3B: API and Drug Product Impurity Guidelines Explained
This comprehensive guide explains how industry professionals can benefit from the ICH Q3A and Q3B guidelines for API and drug product impurities.
FDA Nitrosamine Categorization: Small-Molecule Nitrosamine and NDSRIs
The issue of nitrosamine impurities has become one of the most significant regulatory concerns in the pharmaceutical industry since 2018.
Green Chemistry Approaches in API Impurity Synthesis
Green chemistry is no longer optional in pharmaceutical research. It is essential because the regulatory agencies expect safer processes for chemical development. Also, the companies demand cost efficiency and cleaner reactions.
Drug Substance vs Drug Product: A Simple, Clear Guide for Beginners
If you work in pharmaceuticals, chemistry, biotech, or regulatory affairs, you will hear two terms again and again: drug substance and drug product.
They sound similar, but they mean very different things.
Difference between Process-Related and Degradation-Related Impurities
Understanding the distinctions between Process Impurities and Degradation Impurities is crucial in pharmaceutical development and quality assurance…
Structure Elucidation of Unknown Impurity using LC-MS/MS
Impurity analysis in pharmaceuticals is a critical quality control measure. Impurities, arising during synthesis, storage, or handling, can significantly affect a drug’s safety, efficacy, and stability…
Advancements in LC-MS Technology
Liquid Chromatography-Mass Spectrometry (LC-MS or LC/MS or LCMS) is an indispensable technology in the realm of pharmaceutical analysis…